(Q86309140)

English

Earlier sustained virologic response end points for regulatory approval and dose selection of hepatitis C therapies

scientific article published on 05 March 2013

In more languages
default for all languages
No label defined

No description defined

Statements

Earlier sustained virologic response end points for regulatory approval and dose selection of hepatitis C therapies (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit